TY - JOUR AU - Heidenreich, A. AU - Bastian, P. J. AU - Bellmunt, J. AU - Bolla, M. AU - Joniau, S. AU - van der Kwast, T. PY - 2014 DA - 2014// TI - EAU guidelines on prostate cancer. Part II: treatment of advanced, relapsing, and castration-resistant prostate cancer JO - Eur Urol VL - 65 UR - https://doi.org/10.1016/j.eururo.2013.11.002 DO - 10.1016/j.eururo.2013.11.002 ID - Heidenreich2014 ER - TY - STD TI - Schiller K, Sauter K, Dewes S, Eiber M, Maurer T, Gschwend J, Combs SE, et al. Patterns of failure after radical prostatectomy in prostate cancer - implications for radiation therapy planning after (68)Ga-PSMA-PET imaging. Eur J Nucl Med Mol Imaging. 2017; doi: 10.1007/s00259-017-3746-9. ID - ref2 ER - TY - JOUR AU - Afshar-Oromieh, A. AU - Zechmann, C. AU - Malcher, A. AU - Eder, M. AU - Eisenhut, M. AU - Linhart, H. PY - 2014 DA - 2014// TI - Comparison of PET imaging with a 68Ga-labelled PSMA ligand and 18F-choline-based PET/CT for the diagnosis of recurrent prostate cancer JO - EJNMMI VL - 41 ID - Afshar-Oromieh2014 ER - TY - JOUR AU - Vargas, H. A. AU - Martin-Malburet, A. G. AU - Takeda, T. AU - Corradi, R. B. AU - Eastham, J. AU - Wibmer, A. PY - 2016 DA - 2016// TI - Localizing sites of disease in patients with rising serum prostate-specific antigen up to 1 ng/ml following prostatectomy: how much information can conventional imaging provide? JO - Urol Oncol-Semin Orig Investig VL - 34 ID - Vargas2016 ER - TY - JOUR AU - Panje, C. AU - Panje, T. AU - Putora, P. M. AU - Kim, S. K. AU - Haile, S. AU - Aebersold, D. M. PY - 2015 DA - 2015// TI - Guidance of treatment decisions in risk-adapted primary radiotherapy for prostate cancer using multiparametric magnetic resonance imaging: a single center experience JO - Radiat Oncol VL - 10 UR - https://doi.org/10.1186/s13014-015-0338-3 DO - 10.1186/s13014-015-0338-3 ID - Panje2015 ER - TY - JOUR AU - Hernandez, D. AU - Salas, D. AU - Giménez, D. AU - Buitrago, P. AU - Esquena, S. AU - Palou, J. PY - 2015 DA - 2015// TI - Pelvic MRI findings in relapsed prostate cancer after radical prostatectomy JO - Radiat Oncol VL - 10 UR - https://doi.org/10.1186/s13014-015-0574-6 DO - 10.1186/s13014-015-0574-6 ID - Hernandez2015 ER - TY - JOUR AU - Gupta, M. AU - Choudhury, P. S. AU - Hazarika, D. AU - Rawal, S. A. PY - 2017 DA - 2017// TI - Comparative study of (68)gallium-prostate specific membrane antigen positron emission tomography-computed tomography and magnetic resonance imaging for lymph node staging in high risk prostate cancer patients: an initial experience JO - World J Nucl Med VL - 16 UR - https://doi.org/10.4103/1450-1147.207272 DO - 10.4103/1450-1147.207272 ID - Gupta2017 ER - TY - JOUR AU - Afshar-Oromieh, A. AU - Malcher, A. AU - Eder, M. AU - Eisenhut, M. AU - Linhart, H. G. AU - Hadaschik, B. A. PY - 2013 DA - 2013// TI - PET imaging with a 68Ga-labelled PSMA ligand for the diagnosis of prostate cancer: biodistribution in humans and first evaluation of tumour lesions JO - EJNMMI VL - 40 ID - Afshar-Oromieh2013 ER - TY - JOUR AU - Eder, M. AU - Schafer, M. AU - Bauder-Wust, U. AU - Hull, W. E. AU - Wangler, C. AU - Mier, W. PY - 2012 DA - 2012// TI - 68Ga-complex lipophilicity and the targeting property of a urea-based PSMA inhibitor for PET imaging JO - Bioconjug Chem VL - 23 UR - https://doi.org/10.1021/bc200279b DO - 10.1021/bc200279b ID - Eder2012 ER - TY - JOUR AU - Sweat, S. D. AU - Pacelli, A. AU - Murphy, G. P. AU - Bostwick, D. G. PY - 1998 DA - 1998// TI - Prostate-specific membrane antigen expression is greatest in prostate adenocarcinoma and lymph node metastases JO - Urology VL - 52 UR - https://doi.org/10.1016/S0090-4295(98)00278-7 DO - 10.1016/S0090-4295(98)00278-7 ID - Sweat1998 ER - TY - JOUR AU - Silver, D. A. AU - Pellicer, I. AU - Fair, W. R. AU - Heston, W. D. AU - Cordon-Cardo, C. PY - 1997 DA - 1997// TI - Prostate-specific membrane antigen expression in normal and malignant human tissues JO - Clin Cancer Res VL - 3 ID - Silver1997 ER - TY - JOUR AU - Fendler, W. P. AU - Schmidt, D. F. AU - Wenter, V. AU - Thierfelder, K. M. AU - Zach, C. AU - Stief, C. PY - 2016 DA - 2016// TI - 68Ga-PSMA-HBED-CC PET/CT detects location and extent of primary prostate cancer JO - J Nucl Med VL - 57 UR - https://doi.org/10.2967/jnumed.116.172627 DO - 10.2967/jnumed.116.172627 ID - Fendler2016 ER - TY - JOUR AU - Eiber, M. AU - Weirich, G. AU - Holzapfel, K. AU - Souvatzoglou, M. AU - Haller, B. AU - Rauscher, I. PY - 2016 DA - 2016// TI - Simultaneous (68)Ga-PSMA HBED-CC PET/MRI improves the localization of primary prostate cancer JO - Eur Urol VL - 70 UR - https://doi.org/10.1016/j.eururo.2015.12.053 DO - 10.1016/j.eururo.2015.12.053 ID - Eiber2016 ER - TY - JOUR AU - Maurer, T. AU - Gschwend, J. E. AU - Rauscher, I. AU - Souvatzoglou, M. AU - Haller, B. AU - Weirich, G. PY - 2016 DA - 2016// TI - Diagnostic efficacy of (68)Gallium-PSMA positron emission tomography compared to conventional imaging for lymph node staging of 130 consecutive patients with intermediate to high risk prostate cancer JO - J Urol VL - 195 UR - https://doi.org/10.1016/j.juro.2015.12.025 DO - 10.1016/j.juro.2015.12.025 ID - Maurer2016 ER - TY - JOUR AU - Herlemann, A. AU - Wenter, V. AU - Kretschmer, A. AU - Thierfelder, K. M. AU - Bartenstein, P. AU - Faber, C. PY - 2016 DA - 2016// TI - (68)Ga-PSMA positron emission tomography/computed tomography provides accurate staging of lymph node regions prior to lymph node dissection in patients with prostate cancer JO - Eur Urol VL - 70 UR - https://doi.org/10.1016/j.eururo.2015.12.051 DO - 10.1016/j.eururo.2015.12.051 ID - Herlemann2016 ER - TY - JOUR AU - Afshar-Oromieh, A. AU - Avtzi, E. AU - Giesel, F. AU - Holland-Letz, T. AU - Linhart, H. AU - Eder, M. PY - 2015 DA - 2015// TI - The diagnostic value of PET/CT imaging with the 68Ga-labelled PSMA ligand HBED-CC in the diagnosis of recurrent prostate cancer JO - EJNMMI VL - 42 ID - Afshar-Oromieh2015 ER - TY - JOUR AU - Eiber, M. AU - Maurer, T. AU - Souvatzoglou, M. AU - Beer, A. J. AU - Ruffani, A. AU - Haller, B. PY - 2015 DA - 2015// TI - Evaluation of hybrid 68Ga-PSMA-Ligand PET/CT in 248 patients with biochemical recurrence after radical prostatectomy JO - J Nucl Med VL - 56 UR - https://doi.org/10.2967/jnumed.115.154153 DO - 10.2967/jnumed.115.154153 ID - Eiber2015 ER - TY - JOUR AU - Giesel, F. AU - Fiedler, H. AU - Stefanova, M. AU - Sterzing, F. AU - Rius, M. AU - Kopka, K. PY - 2015 DA - 2015// TI - PSMA PET/CT with Glu-urea-Lys-(Ahx)-[68Ga(HBED-CC)] versus 3D CT volumetric lymph node assessment in recurrent prostate cancer JO - EJNMMI VL - 42 ID - Giesel2015 ER - TY - STD TI - van Leeuwen PJ, Stricker P, Hruby G, Kneebone A, Ting F, Thompson B, et al. (68) Ga-PSMA has a high detection rate of prostate cancer recurrence outside the prostatic fossa in patients being considered for salvage radiation treatment. BJU Int 2016; 117(5):732-739. ID - ref19 ER - TY - JOUR AU - Afshar-Oromieh, A. AU - Holland-Letz, T. AU - Giesel, F. L. AU - Kratochwil, C. AU - Mier, W. AU - Haufe, S. PY - 2017 DA - 2017// TI - Diagnostic performance of (68)Ga-PSMA-11 (HBED-CC) PET/CT in patients with recurrent prostate cancer: evaluation in 1007 patients JO - EJNMMI VL - 44 ID - Afshar-Oromieh2017 ER - TY - JOUR PY - 2014 DA - 2014// TI - World medical association declaration of Helsinki: ethical principles for medical research involving human subjects JO - J Am Coll Dent VL - 81 ID - ref21 ER - TY - JOUR AU - Weineisen, M. AU - Simecek, J. AU - Schottelius, M. AU - Schwaiger, M. AU - Wester, H. -. J. PY - 2014 DA - 2014// TI - Synthesis and preclinical evaluation of DOTAGA-conjugated PSMA ligands for functional imaging and endoradiotherapy of prostate cancer JO - EJNMMI Res VL - 4 UR - https://doi.org/10.1186/s13550-014-0063-1 DO - 10.1186/s13550-014-0063-1 ID - Weineisen2014 ER - TY - STD TI - Clinical Practice Guidelines in Oncology: Prostate Cancer. V.1.2015. http://www.nccn.org/professionals/physician_gls/pdf/prostate.pdf. Accessed 30 Dec 2015. UR - http://nccn.org/professionals/physician_gls/pdf/prostate.pdf ID - ref23 ER - TY - JOUR AU - D’Amico, A. V. AU - Whittington, R. AU - Malkowicz, S. B. AU - Weinstein, M. AU - Tomaszewski, J. E. AU - Schultz, D. PY - 2001 DA - 2001// TI - Predicting prostate specific antigen outcome preoperatively in the prostate specific antigen era JO - J Urol VL - 166 UR - https://doi.org/10.1016/S0022-5347(05)65531-0 DO - 10.1016/S0022-5347(05)65531-0 ID - D’Amico2001 ER - TY - JOUR AU - Ceci, F. AU - Uprimny, C. AU - Nilica, B. AU - Geraldo, L. AU - Kendler, D. AU - Kroiss, A. PY - 2015 DA - 2015// TI - (68)Ga-PSMA PET/CT for restaging recurrent prostate cancer: which factors are associated with PET/CT detection rate? JO - EJNMMI VL - 42 ID - Ceci2015 ER - TY - JOUR AU - Evans, M. J. AU - Smith-Jones, P. M. AU - Wongvipat, J. AU - Navarro, V. AU - Kim, S. AU - Bander, N. H. AU - Larson, S. M. PY - 2011 DA - 2011// TI - Noninvasive measurement of androgen receptor signaling with a positron-emitting radiopharmaceutical that targets prostate-specific membrane antigen JO - Proc Natl Acad Sci VL - 108 UR - https://doi.org/10.1073/pnas.1106383108 DO - 10.1073/pnas.1106383108 ID - Evans2011 ER - TY - JOUR AU - Murga, J. D. AU - Moorji, S. M. AU - Han, A. Q. AU - Magargal, W. W. AU - DiPippo, V. A. AU - Olson, W. C. PY - 2015 DA - 2015// TI - Synergistic co-targeting of prostate-specific membrane antigen and androgen receptor in prostate cancer JO - Prostate VL - 75 UR - https://doi.org/10.1002/pros.22910 DO - 10.1002/pros.22910 ID - Murga2015 ER - TY - JOUR AU - Liu, T. AU - Wu, L. Y. AU - Fulton, M. D. AU - Johnson, J. M. AU - Berkman, C. E. PY - 2012 DA - 2012// TI - Prolonged androgen deprivation leads to downregulation of androgen receptor and prostate-specific membrane antigen in prostate cancer cells JO - Int J Oncol VL - 41 UR - https://doi.org/10.3892/ijo.2012.1649 DO - 10.3892/ijo.2012.1649 ID - Liu2012 ER - TY - JOUR AU - Hope, T. A. AU - Truillet, C. AU - Ehman, E. C. AU - Afshar-Oromieh, A. AU - Aggarwal, R. AU - Ryan, C. J. PY - 2017 DA - 2017// TI - 68Ga-PSMA-11 PET imaging of response to androgen receptor inhibition: first human experience JO - J Nucl Med VL - 58 UR - https://doi.org/10.2967/jnumed.116.181800 DO - 10.2967/jnumed.116.181800 ID - Hope2017 ER - TY - JOUR AU - Wright, G. L. AU - Mayer Grob, B. AU - Haley, C. AU - Grossman, K. AU - Newhall, K. AU - Petrylak, D. PY - 1996 DA - 1996// TI - Upregulation of prostate-specific membrane antigen after androgen-deprivation therapy JO - Urology VL - 48 UR - https://doi.org/10.1016/S0090-4295(96)00184-7 DO - 10.1016/S0090-4295(96)00184-7 ID - Wright1996 ER - TY - JOUR AU - Shakespeare, T. P. PY - 2015 DA - 2015// TI - Effect of prostate-specific membrane antigen positron emission tomography on the decision-making of radiation oncologists JO - Radiat Oncol VL - 10 UR - https://doi.org/10.1186/s13014-015-0548-8 DO - 10.1186/s13014-015-0548-8 ID - Shakespeare2015 ER - TY - JOUR AU - Dewes, S. AU - Schiller, K. AU - Sauter, K. AU - Eiber, M. AU - Maurer, T. AU - Schwaiger, M. PY - 2016 DA - 2016// TI - Integration of (68)Ga-PSMA-PET imaging in planning of primary definitive radiotherapy in prostate cancer: a retrospective study JO - Radiat Oncol VL - 11 UR - https://doi.org/10.1186/s13014-016-0646-2 DO - 10.1186/s13014-016-0646-2 ID - Dewes2016 ER - TY - STD TI - Sterzing F, Kratochwil C, Fiedler H, Katayama S, Habl G, Kopka K, et al. 68Ga-PSMA-11 PET/CT: a new technique with high potential for the radiotherapeutic management of prostate cancer patients. EJNMMI. 2015:1–8. ID - ref33 ER - TY - JOUR AU - Perera, M. AU - Papa, N. AU - Christidis, D. AU - Wetherell, D. AU - Hofman, M. S. AU - Murphy, D. G. PY - 2016 DA - 2016// TI - Sensitivity, specificity, and predictors of positive 68Ga-prostate-specific membrane antigen positron emission tomography in advanced prostate cancer: a systematic review and meta-analysis JO - Eur Urol VL - 70 UR - https://doi.org/10.1016/j.eururo.2016.06.021 DO - 10.1016/j.eururo.2016.06.021 ID - Perera2016 ER - TY - JOUR AU - Bell, L. J. AU - Cox, J. AU - Eade, T. AU - Rinks, M. AU - Herschtal, A. AU - Kneebone, A. PY - 2015 DA - 2015// TI - Determining optimal planning target volume and image guidance policy for post-prostatectomy intensity modulated radiotherapy JO - Radiat Oncol VL - 10 UR - https://doi.org/10.1186/s13014-015-0467-8 DO - 10.1186/s13014-015-0467-8 ID - Bell2015 ER - TY - JOUR AU - Tendulkar, R. D. AU - Agrawal, S. AU - Gao, T. AU - Efstathiou, J. A. AU - Pisansky, T. M. AU - Michalski, J. M. PY - 2016 DA - 2016// TI - Contemporary update of a multi-institutional predictive Nomogram for salvage radiotherapy after radical prostatectomy JO - J Clin Oncol VL - 34 UR - https://doi.org/10.1200/JCO.2016.67.9647 DO - 10.1200/JCO.2016.67.9647 ID - Tendulkar2016 ER - TY - JOUR AU - Pfister, D. AU - Bolla, M. AU - Briganti, A. AU - Carroll, P. AU - Cozzarini, C. AU - Joniau, S. PY - 2014 DA - 2014// TI - Early salvage radiotherapy following radical prostatectomy JO - Eur Urol VL - 65 UR - https://doi.org/10.1016/j.eururo.2013.08.013 DO - 10.1016/j.eururo.2013.08.013 ID - Pfister2014 ER - TY - STD TI - Henkenberens C, von Klot CA, Ross TL, Bengel FM, Wester HJ, Merseburger AS, et al. (68)Ga-PSMA ligand PET/CT-based radiotherapy in locally recurrent and recurrent oligometastatic prostate cancer : early efficacy after primary therapy. Strahlenther Onkol 2016; 192(7):431-439. ID - ref38 ER - TY - JOUR AU - Wu, R. AU - Woodford, H. AU - Capp, A. AU - Hunter, P. AU - Cowin, G. AU - Tai, K. -. H. PY - 2015 DA - 2015// TI - A prospective study of nomogram-based adaptation of prostate radiotherapy target volumes JO - Radiat Oncol VL - 10 UR - https://doi.org/10.1186/s13014-015-0545-y DO - 10.1186/s13014-015-0545-y ID - Wu2015 ER -